BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1312985)

  • 1. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis.
    Fargion S; Mandelli C; Piperno A; Cesana B; Fracanzani AL; Fraquelli M; Bianchi PA; Fiorelli G; Conte D
    Hepatology; 1992 Apr; 15(4):655-9. PubMed ID: 1312985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis.
    Niederau C; Fischer R; Sonnenberg A; Stremmel W; Trampisch HJ; Strohmeyer G
    N Engl J Med; 1985 Nov; 313(20):1256-62. PubMed ID: 4058506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis.
    Fargion S; Fracanzani AL; Piperno A; Braga M; D'Alba R; Ronchi G; Fiorelli G
    Hepatology; 1994 Dec; 20(6):1426-31. PubMed ID: 7982640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and survival in patients with hereditary hemochromatosis and cirrhosis.
    Beaton MD; Adams PC
    Can J Gastroenterol; 2006 Apr; 20(4):257-60. PubMed ID: 16609753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and causes of death in hemochromatosis. Observations in 163 patients.
    Strohmeyer G; Niederau C; Stremmel W
    Ann N Y Acad Sci; 1988; 526():245-57. PubMed ID: 3389643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival in patients with hereditary hemochromatosis.
    Niederau C; Fischer R; Pürschel A; Stremmel W; Häussinger D; Strohmeyer G
    Gastroenterology; 1996 Apr; 110(4):1107-19. PubMed ID: 8613000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survival and development of neoplasms in 56 patients with idiopathic hemochromatosis].
    Fraquelli M; Mandelli C; Cesarini L; Barisani D; Bianchi PA; Conte D
    Ann Ital Med Int; 1992; 7(1):26-9. PubMed ID: 1326311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term results of venesection therapy in idiopathic haemochromatosis.
    Bomford A; Williams R
    Q J Med; 1976 Oct; 45(180):611-23. PubMed ID: 188063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Idiopathic hemochromatosis].
    Marin MG
    Minerva Med; 1985 Mar; 76(13):627-34. PubMed ID: 2986052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venesection therapy in idiopathic haemochromatosis. An analysis of 40 treated and 18 untreated patients.
    Williams R; Smith PM; Spicer EJ; Barry M; Sherlock S
    Q J Med; 1969 Jan; 38(149):1-16. PubMed ID: 4303815
    [No Abstract]   [Full Text] [Related]  

  • 11. Long course and prognostic factors of virus-induced cirrhosis of the liver.
    Gentilini P; Laffi G; La Villa G; Romanelli RG; Buzzelli G; Casini-Raggi V; Melani L; Mazzanti R; Riccardi D; Pinzani M; Zignego AL
    Am J Gastroenterol; 1997 Jan; 92(1):66-72. PubMed ID: 8995940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked iron in liver explants in the absence of major hereditary hemochromatosis gene defects: a risk factor for cardiac failure.
    Fenton H; Torbenson M; Vivekanandan P; Yeh MM; Hart J; Ferrell L
    Transplantation; 2009 Apr; 87(8):1256-60. PubMed ID: 19384175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemochromatosis: course and treatment.
    Sherlock S
    Annu Rev Med; 1976; 27():143-9. PubMed ID: 180870
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis.
    Cacciola I; Filomia R; Alibrandi A; Franzè MS; Caccamo G; Maimone S; Saitta C; Saffioti F; Squadrito G; Raimondo G
    Liver Int; 2018 Jul; 38(7):1220-1229. PubMed ID: 29194934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma arising in the absence of cirrhosis in genetic haemochromatosis: three case reports and review of literature.
    Goh J; Callagy G; McEntee G; O'Keane JC; Bomford A; Crowe J
    Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):915-9. PubMed ID: 10514128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver.
    von Delius S; Lersch C; Schulte-Frohlinde E; Fend F; Dobritz M; Schmid RM; Eckel F
    Z Gastroenterol; 2006 Jan; 44(1):39-42. PubMed ID: 16397838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma in a patient with hereditary hemochromatosis and noncirrhotic liver. A case report.
    Köhler HH; Höhler T; Küsel U; Kirkpatrick CJ; Schirmacher P
    Pathol Res Pract; 1999; 195(7):509-13. PubMed ID: 10448668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cirrhotic process, liver cell carcinoma and extrahepatic malignant tumors in idiopathic haemochromatosis. Study of 71 patients treated with venesection therapy.
    Tiniakos G; Williams R
    Appl Pathol; 1988; 6(2):128-38. PubMed ID: 2839215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis.
    Poon RT; Fan ST; Lo CM; Liu CL; Ng IO; Wong J
    J Clin Oncol; 2000 Mar; 18(5):1094-101. PubMed ID: 10694562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.